T
his decision was made after very rare cases of blood clotting were found among six vaccine recipients in the US.
Health24 spoke to Professor Linda-Gail Bekker about whether this potential side effect is a cause for concern.
Health Minister Zweli Mkhize announced on Tuesday evening that the country would halt the Johnson & Johnson (J&J) Covid-19 vaccine rollout. We have determined to voluntarily suspend our rollout until the causal relationship between the development of clots and the Johnson & Johnson vaccine is sufficiently interrogated, he said. He added that a decision on whether to continue with the rollout would be made within the next few days .
J&J vaccine data will be reviewed over a few days, no concern in SA to date 14 April 2021 - 13:17 By TimesLIVE No major safety issues have been identified in SA thus far regarding the Johnson & Johnson vaccine. File photo. Image: REUTERS/DADO RUVIC
The SA Health Products Regulatory Authority (Sahpra) says no major safety concerns have been identified in the country so far with the J&J Covid-19 vaccine.
The authority, an entity of the national department of health, said it, together with its scientific expert committees, recently reviewed the data from the Sisonke phase 3b implementation study.
“Based on these data, no major safety concerns have been identified. No causal relationship between vaccination and the development of blot clots is evident at this stage.”
Medicines regulator confirms J&J vaccine registration conditions restrict sale to state
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read
Most Read Only the national government can purchase and oversee the rollout of vaccines, bypassing the private sector BL PREMIUM 13 April 2021 - 11:52 Tamar Kahn
SA’s medicines regulator has confirmed that one of the conditions attached to its approval of Johnson & Johnson’s (J&J) Covid-19 vaccine restricts its sale to the national government, Business Day has learnt.
This means that neither provincial governments nor private-sector entities, such as large employers or pharmacies, can buy directly from the vaccine manufacturer, even if it were willing to sell directly to them. J&J and several other vaccine manufacturers have previously indicated they will only sell to the national, but private-sector players have been hopeful that this position will shift at some point.
JUST IN | SA mulling whether to pause J&J Covid-19 shot heraldlive.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldlive.co.za Daily Mail and Mail on Sunday newspapers.